2,5-DIOXOPYRROLIDIN-1-YL 3-(ACETYLTHIO)PROPANOATE, 95.0%, 250mg

TRIETHYLENETETRAMINE TETRAHCL, 60.0%, 500g

Éter monobutílico de propilenglicol, mín. 99 %, para síntesis, 2,5 l, envase de plástico.

2-{2-[(difluoromethyl)sulfanyl]-1h-1,3-benzodiazol-1-yl}acetic acid, 97%, 250mg

Calcium Glycerophosphate>95.0%(T)500g

Pyrimidine-4,6-dicarboxylic acid, 95.0%, 10g

Benzyl (S)-4-methyl-5-oxooxazolidine-3-carboxylate, 98%, 1g

tert-Butyl 3-(hydroxymethyl)-1,4-diazepane-1-carboxylate hydrochloride, 98%, 1g

2H-1,4-Benzoxazin-3(4H)-one, 8-methyl-, 98%, 5g

5-(3-Bromophenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

(S)-2-amino-5-(benzyloxy)pentanoic acid, 98%, 1g

1-(Chloromethyl)-4-(2,2,2-trifluoroethoxy)benzene, 5g

2-(3-Fluoro-2-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 1g